QV Bioelectronics has been selected to present at LSI Europe '26, one of medtech's leading showcase events, in Barcelona this September.
CEO Carl Daintree will take the stage to present GRACE: the world's first fully implantable Tumour Treating Fields device currently in development. GRACE is designed to deliver targeted electric fields continuously from within the body, focusing therapy directly on dividing tumour cells around the clock. Designed for life, not just treatment, GRACE is being built so patients can stay active, independent, and connected to the things they love.
Glioblastoma is where we start. The standard of care hasn't meaningfully changed in 20 years. We're building GRACE to change that.
To connect with the team at LSI Europe '26, get in touch via our Contact page.